Members of the Support Group for Black Patients with Parkinson’s Disease took part in the Parkinson Council’s Walk to…
Articles by Patricia Inácio, PhD
Two leading nonprofit institutes have launched the GA4GH & INCF Neuroscience Community to better connect researchers around the world studying…
The Institute for Glial Sciences, a center dedicated to the role of glial cells in Parkinson’s disease and others…
An ongoing and global Phase 3 clinical trial program for oral tavapadon, a selective dopamine receptor agonist…
Enrollment is now complete for a Phase 2 trial that’s assessing the safety and efficacy of oral vodobatinib (K0706), an…
A trial investigating the feasibility and impact of a novel approach for increasing regular exercise among Hispanic people with…
ABBV-951 (foslevodopa/foscarbidopa) — Abbvie’s continuous infusion formulation of levodopa/carbidopa that’s administered under the skin — will now be…
The Yale School of Medicine has announced it will launch the Stephen and Denise Adams Center for Parkinson’s Disease Research,…
Asha Therapeutics has been selected as a Blue Knight company, joining a public-private initiative that focuses on speeding new…
A new blood test that assesses damage on a particular type of DNA may help in the early diagnosis of…